US Stock MarketDetailed Quotes

UTMD Utah Medical Products

Watchlist
  • 62.910
  • -0.740-1.16%
Close Dec 13 16:00 ET
  • 62.910
  • 0.0000.00%
Post 16:00 ET
213.37MMarket Cap14.70P/E (TTM)

Utah Medical Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-24.70%3.86M
-43.78%2.76M
-23.70%5.28M
5.36%22.28M
-6.13%5.33M
-8.37%5.12M
1.68%4.91M
37.04%6.92M
-0.26%21.15M
13.90%5.68M
Net income from continuing operations
-9.45%3.56M
-17.79%3.45M
-6.12%3.96M
0.98%16.64M
-5.91%4.29M
-8.06%3.94M
2.34%4.2M
19.24%4.21M
11.39%16.47M
10.24%4.56M
Depreciation and amortization
-58.54%740K
-61.05%693K
-61.28%683K
-10.08%6.37M
-40.64%1.04M
2.29%1.79M
0.17%1.78M
-2.49%1.76M
-2.77%7.08M
-1.18%1.75M
Deferred tax
63.19%-53K
-26.77%-161K
-18,200.00%-183K
-72.41%-681K
-3,021.43%-409K
-17.07%-144K
10.56%-127K
99.31%-1K
-645.28%-395K
-85.42%14K
Change In working capital
11.13%-447K
-32.74%-1.28M
-15.56%749K
89.53%-233K
148.46%345K
-45.38%-503K
0.21%-962K
534.80%887K
-121.27%-2.23M
32.89%-712K
-Change in receivables
-110.11%-9K
-132.55%-83K
-111.96%-214K
532.38%2.27M
-74.34%137K
107.67%89K
-62.50%255K
409.52%1.79M
53.54%-525K
262.80%534K
-Change in inventory
-79.06%67K
205.59%170K
125.00%271K
71.53%-670K
188.54%255K
128.19%320K
-33.06%-161K
-33.99%-1.08M
-385.15%-2.35M
11.11%-288K
-Change in prepaid assets
-43.75%9K
700.00%132K
-448.00%-87K
170.31%45K
144.07%26K
-61.90%16K
-135.48%-22K
122.94%25K
20.99%-64K
-28.26%-59K
-Change in payables and accrued expense
44.61%-514K
-44.68%-1.5M
396.18%779K
-362.29%-1.88M
91.88%-73K
-148.64%-928K
34.76%-1.03M
-87.85%157K
3.77%716K
-147.66%-899K
Cash from discontinued investing activities
Operating cash flow
-24.70%3.86M
-43.78%2.76M
-23.70%5.28M
5.36%22.28M
-6.13%5.33M
-8.37%5.12M
1.68%4.91M
37.04%6.92M
-0.26%21.15M
13.90%5.68M
Investing cash flow
Cash flow from continuing investing activities
52.15%-89K
64.06%-115K
111.63%5K
21.88%-639K
-136.84%-90K
42.06%-186K
-44.14%-320K
81.86%-43K
-48.19%-818K
84.98%-38K
Capital expenditure reported
49.46%-94K
65.63%-110K
48.84%-22K
21.88%-639K
---90K
---186K
-44.14%-320K
81.86%-43K
---818K
----
Net PPE purchase and sale
--0
--0
--27K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
52.15%-89K
64.06%-115K
111.63%5K
21.88%-639K
-136.84%-90K
42.06%-186K
-44.14%-320K
81.86%-43K
-48.19%-818K
84.98%-38K
Financing cash flow
Cash flow from continuing financing activities
-375.17%-4.92M
-611.88%-7.19M
-279.69%-3.98M
24.05%-4.17M
-16.41%-1.07M
-0.29%-1.04M
71.56%-1.01M
-5,621.05%-1.05M
49.71%-5.48M
88.60%-920K
Net common stock issuance
---3.87M
---6.4M
---2.99M
--0
--0
--0
--0
--0
---2.5M
--0
Cash dividends paid
1.77%-1.05M
-1.03%-1.08M
-1.78%-1.09M
-35.38%-4.28M
-1.90%-1.07M
-1.81%-1.07M
-0.94%-1.07M
---1.07M
72.41%-3.16M
87.41%-1.05M
Proceeds from stock option exercised by employees
--0
390.00%294K
357.14%96K
-32.76%117K
--0
80.00%36K
1,400.00%60K
10.53%21K
-68.93%174K
-53.05%131K
Cash from discontinued financing activities
Financing cash flow
-375.17%-4.92M
-611.88%-7.19M
-279.69%-3.98M
24.05%-4.17M
-16.41%-1.07M
-0.29%-1.04M
71.56%-1.01M
-5,621.05%-1.05M
49.71%-5.48M
88.60%-920K
Net cash flow
Beginning cash position
5.44%89.22M
15.94%93.81M
23.74%92.87M
23.09%75.05M
26.90%88.21M
27.78%84.62M
22.83%80.91M
23.09%75.05M
18.19%60.97M
8.07%69.51M
Current changes in cash
-129.51%-1.15M
-226.79%-4.54M
-77.71%1.3M
17.73%17.48M
-11.67%4.17M
-7.93%3.9M
238.34%3.58M
20.61%5.82M
52.32%14.85M
241.55%4.72M
Effect of exchange rate changes
223.87%384K
-137.10%-46K
-1,067.57%-358K
144.20%339K
-40.42%488K
67.33%-310K
117.51%124K
-47.89%37K
-111.88%-767K
7,545.45%819K
End cash Position
0.28%88.45M
5.44%89.22M
15.94%93.81M
23.74%92.87M
23.74%92.87M
26.90%88.21M
27.78%84.62M
22.83%80.91M
23.09%75.05M
23.09%75.05M
Free cash flow
-23.67%3.77M
-42.37%2.65M
-23.54%5.25M
6.46%21.64M
-7.09%5.24M
-6.32%4.94M
-0.37%4.59M
42.90%6.87M
-1.56%20.33M
19.18%5.64M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -24.70%3.86M-43.78%2.76M-23.70%5.28M5.36%22.28M-6.13%5.33M-8.37%5.12M1.68%4.91M37.04%6.92M-0.26%21.15M13.90%5.68M
Net income from continuing operations -9.45%3.56M-17.79%3.45M-6.12%3.96M0.98%16.64M-5.91%4.29M-8.06%3.94M2.34%4.2M19.24%4.21M11.39%16.47M10.24%4.56M
Depreciation and amortization -58.54%740K-61.05%693K-61.28%683K-10.08%6.37M-40.64%1.04M2.29%1.79M0.17%1.78M-2.49%1.76M-2.77%7.08M-1.18%1.75M
Deferred tax 63.19%-53K-26.77%-161K-18,200.00%-183K-72.41%-681K-3,021.43%-409K-17.07%-144K10.56%-127K99.31%-1K-645.28%-395K-85.42%14K
Change In working capital 11.13%-447K-32.74%-1.28M-15.56%749K89.53%-233K148.46%345K-45.38%-503K0.21%-962K534.80%887K-121.27%-2.23M32.89%-712K
-Change in receivables -110.11%-9K-132.55%-83K-111.96%-214K532.38%2.27M-74.34%137K107.67%89K-62.50%255K409.52%1.79M53.54%-525K262.80%534K
-Change in inventory -79.06%67K205.59%170K125.00%271K71.53%-670K188.54%255K128.19%320K-33.06%-161K-33.99%-1.08M-385.15%-2.35M11.11%-288K
-Change in prepaid assets -43.75%9K700.00%132K-448.00%-87K170.31%45K144.07%26K-61.90%16K-135.48%-22K122.94%25K20.99%-64K-28.26%-59K
-Change in payables and accrued expense 44.61%-514K-44.68%-1.5M396.18%779K-362.29%-1.88M91.88%-73K-148.64%-928K34.76%-1.03M-87.85%157K3.77%716K-147.66%-899K
Cash from discontinued investing activities
Operating cash flow -24.70%3.86M-43.78%2.76M-23.70%5.28M5.36%22.28M-6.13%5.33M-8.37%5.12M1.68%4.91M37.04%6.92M-0.26%21.15M13.90%5.68M
Investing cash flow
Cash flow from continuing investing activities 52.15%-89K64.06%-115K111.63%5K21.88%-639K-136.84%-90K42.06%-186K-44.14%-320K81.86%-43K-48.19%-818K84.98%-38K
Capital expenditure reported 49.46%-94K65.63%-110K48.84%-22K21.88%-639K---90K---186K-44.14%-320K81.86%-43K---818K----
Net PPE purchase and sale --0--0--27K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow 52.15%-89K64.06%-115K111.63%5K21.88%-639K-136.84%-90K42.06%-186K-44.14%-320K81.86%-43K-48.19%-818K84.98%-38K
Financing cash flow
Cash flow from continuing financing activities -375.17%-4.92M-611.88%-7.19M-279.69%-3.98M24.05%-4.17M-16.41%-1.07M-0.29%-1.04M71.56%-1.01M-5,621.05%-1.05M49.71%-5.48M88.60%-920K
Net common stock issuance ---3.87M---6.4M---2.99M--0--0--0--0--0---2.5M--0
Cash dividends paid 1.77%-1.05M-1.03%-1.08M-1.78%-1.09M-35.38%-4.28M-1.90%-1.07M-1.81%-1.07M-0.94%-1.07M---1.07M72.41%-3.16M87.41%-1.05M
Proceeds from stock option exercised by employees --0390.00%294K357.14%96K-32.76%117K--080.00%36K1,400.00%60K10.53%21K-68.93%174K-53.05%131K
Cash from discontinued financing activities
Financing cash flow -375.17%-4.92M-611.88%-7.19M-279.69%-3.98M24.05%-4.17M-16.41%-1.07M-0.29%-1.04M71.56%-1.01M-5,621.05%-1.05M49.71%-5.48M88.60%-920K
Net cash flow
Beginning cash position 5.44%89.22M15.94%93.81M23.74%92.87M23.09%75.05M26.90%88.21M27.78%84.62M22.83%80.91M23.09%75.05M18.19%60.97M8.07%69.51M
Current changes in cash -129.51%-1.15M-226.79%-4.54M-77.71%1.3M17.73%17.48M-11.67%4.17M-7.93%3.9M238.34%3.58M20.61%5.82M52.32%14.85M241.55%4.72M
Effect of exchange rate changes 223.87%384K-137.10%-46K-1,067.57%-358K144.20%339K-40.42%488K67.33%-310K117.51%124K-47.89%37K-111.88%-767K7,545.45%819K
End cash Position 0.28%88.45M5.44%89.22M15.94%93.81M23.74%92.87M23.74%92.87M26.90%88.21M27.78%84.62M22.83%80.91M23.09%75.05M23.09%75.05M
Free cash flow -23.67%3.77M-42.37%2.65M-23.54%5.25M6.46%21.64M-7.09%5.24M-6.32%4.94M-0.37%4.59M42.90%6.87M-1.56%20.33M19.18%5.64M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List